Assessment of Patient Satisfaction and Preferences With Inhalers in Asthma With the FSI-10 Questionnaire

Tordera, Miguel Perpiñá; Viejo, José Luís; Sanchos, Joaquín; Badı́a, Xavier; Cobos, N.; Picado, César; Sobradillo, V.; Río, Jaime Martínez González del; Duce, F.; Cabrera, Luís Muñoz

doi:10.1016/s1579-2129(08)60060-9

Cited by 45 publications

(39 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The findings of our study are in-line with those of Perpiñá Tordera et al [27] who investigated patient satisfaction and preference for three different inhalers, Novolizer, Turbuhaler, and Accuhaler after one week of use. In the younger age group below 16 years, the preferred inhaler was Novolizer (60%) while Turbuhaler and Accuhaler were only preferred by 20% of patients in each case (P = 0.04).…”

Section: Previous Inhaler Usesupporting

confidence: 92%

A Multicenter Observational Prospective Study of the Preferred Inhaler After a Switch of Therapy in Asthma Patients

Wille

Fircks²

2015

Pulm Ther

View full text Add to dashboard Cite

Introduction: Poor compliance and incorrect handling of inhaler devices is common among patients with asthma using traditional dry powder inhalers, and patient preference and perception of ease of handling are important. The aim of this study was to determine the proportion of patients preferring the recently introduced Novopulmon Ò Novolizer Ò device (Meda, Sweden) compared with their previous inhaler device. Methods: An observational study was conducted among 258 asthma patients in Sweden. Patients aged C6 years, receiving maintenance treatment with inhaled corticosteroids, and requiring a switch to another inhaler were included. Patients completed a questionnaire regarding the preference, appearance, handling, instructions for use, dose control, and global perception of the inhaler upon switching the device and again after 2 months' use of the new device. Results: Patients were aged from 6 to 85 years. Almost all patients (98%) were switched to the Novolizer inhaler. The majority of patients preferred Novolizer versus their previous inhaler: 92.4% [95% confidence interval (CI) 86.0-96.5%] in the 6-12 years age group, 90.9% (95% CI 70.8-98.9%) in the 13-17 years group, and 83.3% (95% CI 74.4-90.2%) among those aged C18 years. The results from 10 questions related to the inhalation process and device handling demonstrated that Novopulmon Novolizer was evaluated by patients as superior compared with Turbuhaler Ò (AstraZeneca), Diskus Ò (GlaxoSmithKline) and Easyhaler Ò

show abstract

Section: Previous Inhaler Usesupporting

confidence: 92%

A Multicenter Observational Prospective Study of the Preferred Inhaler After a Switch of Therapy in Asthma Patients

Wille

Fircks²

2015

Pulm Ther

View full text Add to dashboard Cite

show abstract

“…The FSI-10 (Feeling of Satisfaction with Inhaler) questionnaire is designed to determine the ease of use and patient satisfaction in relation to different inhalers, irrespective of the drug used [17].…”

Section: Introductionmentioning

confidence: 99%

Critical Steps: A Non-Interventional, Multicenter, Prospective, Observational Study on Critical Handling Errors with DPI Use, in Asthma and COPD Patients

Bouros¹,

Evangeliou²

2016

J Pulm Respir Med

View full text Add to dashboard Cite

Objective: Correct inhalation technique is crucial for drug delivery to the airways of Asthma and COPD patients. The aim of the current study is to assess the usability of three commonly used DPI devices in Greece in Asthma and COPD patients. Methods:This was a non-interventional, multicenter, observational study that enrolled 755 patients (409 Asthma and 346 COPD). Evaluation of device use was performed at baseline (day 0), immediately after correct use demonstration by the investigator, and final visit (day 30). Assessment was based on 8-step device-specific checklists where all the required inhalation maneuvers were described. Primary variable was the number of critical errors observed during baseline and final visit. The ACQ and CAT questionnaires were used to record patients' perspective about their condition, and the FSI-10 questionnaire to depict patients' feeling of satisfaction from inhaler use.Results: More than 70% of the patients performed all inhalation maneuvers correctly right after the first demonstration by pneumonologist. At final visit approximately 85% of Diskus ® , 93% of Elpenhaler ® , and 75% of Turbuhaler ® users did not make critical errors that affect drug delivery to the lungs. Elpenhaler ® had the lower error rates for critical steps at baseline and final visits (7.0% and 2.5% respectively), whereas the corresponding rates for Diskus ® were 7.3% and 4.9%, and for Turbuhaler ® , 8.5% and 7% respectively. All patients had improved ACQ and CAT scores and were at least fairly satisfied by their inhalers. Conclusions:Demonstration of inhalation technique is of paramount importance, while prescribing an inhaled therapy. Improvement over one-month use was more evident in Elpenhaler ® device. The lower error rates on critical steps for Elpenhaler ® reported at baseline and final visits in combination with the observed improvements in ACQ, CAT and FSI-10 scores suggest better adherence to therapy and disease control.

show abstract

“…The FSI-10 is a validated, self-report instrument containing 10 questions, each requiring a response on a 5-point Likert scale (very, fairly, somewhat, not very, and hardly at all) scored from 5 to 1, respectively. The original instrument, designed for an inhaler, assesses the level of satisfaction with a device and includes items on ease or difficulty of use, portability, and usability (11). The adapted instrument is included as Supplementary Material.…”

Section: Methodsmentioning

confidence: 99%

Biometric Digital Health Technology for Measuring Motor Function in Parkinson’s Disease: Results from a Feasibility and Patient Satisfaction Study

et al. 2017

View full text Add to dashboard Cite

ObjectivesTo assess the feasibility, predictive value, and user satisfaction of objectively quantifying motor function in Parkinson’s disease (PD) through a tablet-based application (iMotor) using self-administered tests.MethodsPD and healthy controls (HCs) performed finger tapping, hand pronation–supination and reaction time tasks using the iMotor application.ResultsThirty-eight participants (19 with PD and 17 HCs) were recruited in the study. PD subjects were 53% male, with a mean age of 67.8 years (±8.8), mean disease duration of 6.5 years (±4.6), Movement Disorders Society version of the Unified Parkinson Disease Rating Scale III score 26.3 (±6.7), and Hoehn & Yahr stage 2. In the univariate analysis, most tapping variables were significantly different in PD compared to HC. Tap interval provided the highest predictive ability (90%). In the multivariable logistic regression model reaction time (reaction time test) (p = 0.021) and total taps (two-target test) (p = 0.026) were associated with PD. A combined model with two-target (total taps and accuracy) and reaction time produced maximum discriminatory performance between HC and PD. The overall accuracy of the combined model was 0.98 (95% confidence interval: 0.93–1). iMotor use achieved high rates of patients’ satisfaction as evaluated by a patient satisfaction survey.ConclusioniMotor differentiated PD subjects from HCs using simple alternating tasks of motor function. Results of this feasibility study should be replicated in larger, longitudinal, appropriately designed, controlled studies. The impact on patient care of at-home iMotor-assisted remote monitoring also deserves further evaluation.

show abstract

Assessment of Patient Satisfaction and Preferences With Inhalers in Asthma With the FSI-10 Questionnaire

Cited by 45 publications

References 16 publications

A Multicenter Observational Prospective Study of the Preferred Inhaler After a Switch of Therapy in Asthma Patients

A Multicenter Observational Prospective Study of the Preferred Inhaler After a Switch of Therapy in Asthma Patients

Critical Steps: A Non-Interventional, Multicenter, Prospective, Observational Study on Critical Handling Errors with DPI Use, in Asthma and COPD Patients

Biometric Digital Health Technology for Measuring Motor Function in Parkinson’s Disease: Results from a Feasibility and Patient Satisfaction Study

Contact Info

Product

Resources

About